Danielle P. Johnson

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Douglas Burtrum, Zhenping Zhu, Dan Lu et al. · PubMed · 2003 · 349 citations

Human Growth, Immunology, Insulin Binding +17

HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia

S Tharkar-Promod, Danielle P. Johnson, Samuel Bennett et al. · Leukemia · 2017 · 44 citations · Full text

HDAC1,2 inhibition impairs EZH2- and BBAP- mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma

Danielle P. Johnson, Gabriella S. Spitz, Shweta Tharkar et al. · Oncotarget · 2014 · 38 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Hdac1,2 Inhibition +13

Preclinical Ultra-High Dose Rate (FLASH) Proton Radiation Therapy System for Small Animal Studies

Ning Cao, Danielle P. Johnson, Eric C. Ford et al. · Advances in Radiation Oncology · 2023 · 17 citations · Full text